Small Molecules
26 June 2018
FDA Grants Priority Review to Genentech’s Baloxavir Marboxil for the Treatment of Influenza25 June 2018
CellCentric enters clinic with first-in-class p300/CBP inhibitor for late-stage prostate cancer22 June 2018
Nanobiotix announces positive phase II/III topline data in soft tissue sarcoma with NBTXR321 June 2018
Reata Announces Initiation of a Phase 1 Trial of RTA 1701, a Selective, Oral Allosteric Inhibitor of RORγt20 June 2018
Idorsia initiates PRECISION – Phase 3 study with aprocitentan for resistant hypertension management19 June 2018
Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency DisorderNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports